Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity.
about
A method for identification and analysis of non-overlapping myeloid immunophenotypes in humansClinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanomaComplexity and challenges in defining myeloid-derived suppressor cellsIncreased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patientsHarnessing the PD-1 pathway in renal cell carcinoma: current evidence and future directionsMyeloid-derived suppressor cells as effectors of immune suppression in cancer.Pembrolizumab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechanisms.High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy.Blood monocytes sample MelanA/MART1 antigen for long-lasting cross-presentation to CD8+ T cells after differentiation into dendritic cells.Activation of central/effector memory T cells and T-helper 1 polarization in malignant melanoma patients treated with anti-programmed death-1 antibody
P2860
Q27310807-E25C03FF-C224-4857-88A3-02F167BBDD00Q35078852-D49F1E7B-F26E-4C88-BB7A-DD9E80B75DDBQ35509317-45DA567C-3D58-42EB-BCF8-CB5BAE125D6BQ35965142-A406B998-5A25-452F-9E08-F1B72317854FQ36954166-EBCAC960-44AF-4B3B-9A26-A168562A66EBQ38864758-9F0E607A-51B2-4BB6-BB79-38A9D27DF8C5Q39369955-9759B7B3-2F40-4FF3-B496-C4F31DAE56A4Q47225234-4BAD9F0F-F896-40A1-AAC7-FFBFDE89557BQ47836358-D09FEEA0-032D-4542-8251-007D826B4793Q58778777-35F7BAED-155F-4846-82B1-4EADB73074A7
P2860
Untreated stage IV melanoma patients exhibit abnormal monocyte phenotypes and decreased functional capacity.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Untreated stage IV melanoma pa ...... decreased functional capacity.
@en
Untreated stage IV melanoma pa ...... decreased functional capacity.
@nl
type
label
Untreated stage IV melanoma pa ...... decreased functional capacity.
@en
Untreated stage IV melanoma pa ...... decreased functional capacity.
@nl
prefLabel
Untreated stage IV melanoma pa ...... decreased functional capacity.
@en
Untreated stage IV melanoma pa ...... decreased functional capacity.
@nl
P2093
P2860
P1476
Untreated stage IV melanoma pa ...... decreased functional capacity.
@en
P2093
Michael P Gustafson
Rahul Chavan
Svetomir N Markovic
Wendy Nevala
P2860
P304
P356
10.1158/2326-6066.CIR-13-0094
P577
2013-11-18T00:00:00Z